No takes yet. Share an insight, caveat, or question.
Preclinical study demonstrates tumor regression from Chol-R9-delivered VEGF siRNA in a colon adenocarcinoma model, indicating a potential local gene therapy approach.
Kim et al. (2006) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: